Gainers

 

  • vTv Therapeutics Inc.VTVT rose 55.8 percent to $4.44 in pre-market trading after the company late Tuesday announced two Alzheimer’s presentations at the 11th CTAD conference.
  • Oragenics IncOGEN rose 29.8 percent to $1.48 in pre-market trading after the company received clearance from The Belgian Health Authority to enroll patients into its Phase 2 clinical trial of AG013 for oral mucositis.
  • Vicor CorporationVICR rose 21.8 percent to $46.75 in pre-market trading following Q3 earnings.
  • Netflix, Inc.NFLX rose 11.2 percent to $385.24 in pre-market trading after the company reported stronger-than-expected earnings for its third quarter. The company had total streaming net additions of 6.96 million.
  • AzurRx BioPharma, Inc.AZRX rose 8 percent to $2.70 in pre-market trading.
  • ENDRA Life Sciences Inc.NDRA rose 6.4 percent to $3.00 in pre-market trading after gaining 12.35 percent on Tuesday.
  • Winnebago Industries, Inc.WGO rose 6.3 percent to $33.75 in pre-market trading after reporting upbeat Q4 earnings.
  • Lam Research Corporation LRCXshares rose 5.9 percent to $153.78 in pre-market trading after the company reported upbeat quarterly earnings.
  • LexinFintech Holdings Ltd.LX rose 5.8 percent to $10.40 in pre-market trading after climbing 4.35 percent on Tuesday.
  • United Continental Holdings, Inc. UALrose 5.7 percent to $88.25 in pre-market trading after reporting Q3 earnings.
  • Moody’s Corporation MCOrose 5.1 percent to $167.80 in pre-market trading. Moody’s named Derek Vadala as Global Head of Cyber Risk for Moody’s Investors Service.
  • KLA-Tencor Corporation KLACshares rose 4.4 percent to $97.00 in pre-market trading after climbing 2.05 percent on Tuesday.
  • Akorn, Inc.AKRX rose 4.3 percent to $7.00 in pre-market trading after surging 7.19 percent on Tuesday.
  • American Airlines Group Inc.AAL rose 4 percent to $34.60 in pre-market trading. Deutsche Bank upgraded American Airlines from Hold to Buy and raised the price target from $40 to $47.
  • 22nd Century Group, Inc.XXII rose 4 percent to $3.14 in pre-market trading after jumping 6.34 percent on Tuesday.
  • Delta Air Lines, Inc. DALrose 3.5 percent to $54.96 in pre-market trading. Deutsche Bank upgraded Delta Air Lines from Hold to Buy and raised the price target from $53 to $60.
  • ASML Holding N.V. ASMLrose 3.3 percent to $187.67 in pre-market trading following Q3 earnings.
  • iQIYI, Inc. IQrose 3.1 percent to $26.72 in pre-market trading. iQIYI signed an international distribution agreement with Viacom for the second season of children’s animation series Deer Run.
  • Cree, Inc.CREE rose 2.5 percent to $38.39 in pre-market trading after the company reported upbeat results for its first quarter and issued strong second-quarter guidance.

 

Losers

  • Fresenius Medical Care AG & Co. KGaA FMSfell 18.2 percent to $40.83 in pre-market trading.
  • Blink Charging Co.BLNK fell 10.7 percent to $3.18 in pre-market trading after rising 62.56 percent on Tuesday.
  • Tekla Healthcare Investors HQHshares fell 8.6 percent to $20.00 in pre-market trading after rising 3.65 percent on Tuesday.
  • Hi-Crush Partners LP HCLPshares fell 7.8 percent to $8.75 in pre-market trading.
  • Youngevity International, Inc.YGYI fell 7.3 percent to $13.90 in pre-market trading after falling 5.54 percent on Tuesday.
  • Smart Sand, Inc.SND fell 7.1 percent to $3.55 in pre-market trading.
  • Del Taco Restaurants, Inc.TACO shares fell 6.8 percent to $10.19 in pre-market trading.
  • Consumer Portfolio Services, Inc.CPSS shares fell 6.1 percent to $3.39 in pre-market trading after rising 2.87 percent on Tuesday.
  • XTL Biopharmaceuticals Ltd. XTLB 3.01%fell 5.6 percent to $2.68 in pre-market trading after dropping 4.06 percent on Tuesday.
  • Fuwei Films (Holdings) Co., Ltd.FFHL fell 5.6 percent to $2.02 in pre-market trading after surging 23.70 percent on Tuesday.
  • SVMK Inc.SVMK shares fell 5.1 percent to $12.40 in pre-market.
  • International Business Machines Corporation IBMfell 4.8 percent to $138.12 in pre-market trading. IBM reported upbeat earnings for its third quarter, while sales missed estimates. The company reaffirmed FY18 guidance.